查詢結果分析
相關文獻
- Application of Coronary Stent in Treating Hepatic Artery Stenosis in a Liver-grafted Patient
- 簡介冠狀動脈支架(Stents)與其藥物治療
- The First Multicenter Coronary Stenting Registration in Taiwan
- 臺灣安置冠狀動脈支架的經驗
- 病人的選擇與適應症[冠狀動脈病]
- 成效與併發症[冠狀動脈支架術]
- 心臟外科的觀點[冠狀動脈支架術]
- 未來展望[冠狀動脈支架術]
- 小兒肝移植的手術中、手術後管理
- Primary Percutaneous Transluminal Coronary Angioplasty and Primary Stenting for Patients with Acute Myocardial Infarction--A Single Center Experience
頁籤選單縮合
題名 | Application of Coronary Stent in Treating Hepatic Artery Stenosis in a Liver-grafted Patient=在肝臟移植後病人使用冠狀動脈支架治療肝動脈狹窄 |
---|---|
作 者 | 楊仲棋; 鄭正忠; 謝宗保; 曾炳憲; | 書刊名 | Acta Cardiologica Sinica |
卷期 | 19:4 2003.12[民92.12] |
頁次 | 頁259-262 |
分類號 | 416.263 |
關鍵詞 | 肝動脈狹窄; 肝移植; 冠狀動脈支架; Hepatic artery stenosis; Liver transplantation; Coronary stenting; |
語文 | 英文(English) |
中文摘要 | 肝動脈阻塞是肝臟移植後的併發症之一。它可以導致移植肝的衰竭。早期診斷和治療扮演重要的角色。我們報告一位肝臟移植後肝動阻塞的病人,成功地接受肝動脈內冠狀動脈支架置放。一位四十四歲男性罹患肝癌並接受肝臟移植。肝動脈阻塞於兩個月後發生於接合處合併血清轉胺酶升高。他接受經皮肝動脈血管成型術及血管內冠狀動脈支架置放。剩餘阻塞率為百分之零。血清轉胺酶於術後快速地降至正常範圍。早期治療肝動脈阻塞於肝臟移植後,可避免嚴重的併發症。肝動脈內冠狀動脈支架置放是一個方便又有效的方法。它的長期預後和阻塞率需要更進一步追蹤和觀察。 |
英文摘要 | Hepatic atrtery stenosis is one of the vascular complications after liver transplantation that may lead to graft failure. Thus, early diagnosis and effective treatment is critical to prevent the occurrence of this complication. Here, we report a successful treatment of a lever-graft patient with hepatic artery stenonsis with a coronary stent. A 44-year-old man who suffered from hepatocellular carcinoma one year previous to admission received liver transplantation due to multifocal metastasis. However, hepatic artery stenosis over the anastomotic site with elevated serum aminotransferase was detected two moths after the surgery. He was treated with percutaneous transluminal hepatic angioplasty and coronary stent, with 0% residual steonsis and serum aminotransferase returned to normal range almost immediately. Early treatment of hepatic artery stenosis by stenting seems to be safe and effective in preventing severe complication associated with liver tansplantation. However, its efficacy as well as the morbidity and mortality rate of patient should be monitored by a long-term follow-up. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。